{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T09:30:31Z","timestamp":1785403831738,"version":"3.56.0"},"reference-count":53,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T00:00:00Z","timestamp":1781913600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015624","name":"University of Jeddah","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100015624","id-type":"DOI","asserted-by":"crossref"}]},{"id":[{"id":"https:\/\/ror.org\/015ya8798","id-type":"ROR","asserted-by":"publisher"}]},{"name":"UKRI Medical Research Council","award":["MR\/N0199016\/1"],"award-info":[{"award-number":["MR\/N0199016\/1"]}]},{"name":"National Institute of Health and Care Research","award":["II-LA-1117\u20132001"],"award-info":[{"award-number":["II-LA-1117\u20132001"]}]},{"DOI":"10.13039\/100014013","name":"Medical Research Council Clinician Scientist Fellowship","doi-asserted-by":"publisher","award":["UKRI2441"],"award-info":[{"award-number":["UKRI2441"]}],"id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Birmingham Health Partners (BHP) Clinician Scientist Fellowship"},{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","award":["UKRI2441"],"award-info":[{"award-number":["UKRI2441"]}],"id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]},{"award":["UKRI2441"],"award-info":[{"award-number":["UKRI2441"]}],"id":[{"id":"https:\/\/ror.org\/001aqnf71","id-type":"ROR","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000615","name":"Fight for Sight PhD Studentship","doi-asserted-by":"publisher","award":["RESPHD2505"],"award-info":[{"award-number":["RESPHD2505"]}],"id":[{"id":"10.13039\/501100000615","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000305","name":"Sight Research UK","doi-asserted-by":"publisher","award":["TRN008_Ting_Birmingham"],"award-info":[{"award-number":["TRN008_Ting_Birmingham"]}],"id":[{"id":"10.13039\/501100000305","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Staphylococcus aureus is a leading cause of bacterial keratitis and antimicrobial resistance-associated death globally. This study aimed to evaluate the efficacy of CaD23, a human-derived hybrid antimicrobial peptide (AMP), in combination with antibiotics in treating S. aureus infections. The efficacy of CaD23 and six medically important antibiotics (amikacin, cefuroxime, chloramphenicol, fosfomycin, vancomycin and levofloxacin) was examined against six strains of methicillin-sensitive and methicillin-resistant S. aureus using a minimum inhibitory concentration (MIC) assay. CaD23\u2013antibiotic interactions were evaluated using checkerboard and time\u2013kill kinetics assays. 3,3\u2032-dipropylthiadicarbocyanine iodide (DiSC3,5) cytoplasmic membrane depolarisation assay was performed to examine the mechanism of action. Overall, CaD23 exhibited good efficacy against all MSSA and MRSA (MIC = 16\u201332 \u03bcg\/mL [6.7\u201313.3 \u03bcM]). Of 20 peptide\u2013antibiotic\u2013organism combinations, 19 (95%) combinations demonstrated positive interactions, with six (31.6%) and 13 (68.4%) exhibiting synergistic (FICI = 0.293\u20130.412) and additive effects (FICI = 0.521\u20130.890), respectively. CaD23 was able to achieve complete bacterial eradication significantly faster than cefuroxime and levofloxacin (15 min vs. 8\u201324 h). When used at a sub-MIC concentration, CaD23 could accelerate the killing of S. aureus of cefuroxime from 8\u201324 h to within 1 h and enhance the activity of levofloxacin by 90%. CaD23 was shown to rapidly depolarise the inner membrane of S. aureus within seconds of the treatment. In conclusion, CaD23\u2013antibiotic combination therapy serves as a useful strategy for tackling drug-resistant ocular and systemic S. aureus infections.<\/jats:p>","DOI":"10.3390\/ijms27125573","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T03:09:17Z","timestamp":1782270557000},"page":"5573","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of Antimicrobial Peptide\u2013Antibiotic Combination Treatment for Tackling Ocular and Systemic Staphylococcus aureus Infections"],"prefix":"10.3390","volume":"27","author":[{"given":"Eman Khalid","family":"Barahim","sequence":"first","affiliation":[{"name":"Academic Unit of Ophthalmology, Department of Inflammation and Ageing, School of Infection, Inflammation and Immunology, College of Medicine and Health, University of Birmingham, Birmingham B15 2TT, UK"},{"name":"Department of Biological Sciences, College of Sciences, University of Jeddah, Jeddah 21589, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ella P.","family":"Smith","sequence":"additional","affiliation":[{"name":"Academic Unit of Ophthalmology, Department of Inflammation and Ageing, School of Infection, Inflammation and Immunology, College of Medicine and Health, University of Birmingham, Birmingham B15 2TT, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheau Ting","family":"Yong","sequence":"additional","affiliation":[{"name":"Academic Unit of Ophthalmology, Department of Inflammation and Ageing, School of Infection, Inflammation and Immunology, College of Medicine and Health, University of Birmingham, Birmingham B15 2TT, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thet Tun","family":"Aung","sequence":"additional","affiliation":[{"name":"Singapore Eye Research Institute, Singapore National Eye Centre, Singapore 169856, Singapore"},{"name":"Ophthalmology and Visual Sciences Academic Clinical Program (EYE-ACP), Duke-NUS Medical School, Singapore 169857, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8214-5315","authenticated-orcid":false,"given":"Rajamani","family":"Lakshminarayanan","sequence":"additional","affiliation":[{"name":"Singapore Eye Research Institute, Singapore National Eye Centre, Singapore 169856, Singapore"},{"name":"Ophthalmology and Visual Sciences Academic Clinical Program (EYE-ACP), Duke-NUS Medical School, Singapore 169857, Singapore"},{"name":"Department of Pharmacy and Pharmaceutical Sciences, National University of Singapore, Singapore 117543, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imran","family":"Mohammed","sequence":"additional","affiliation":[{"name":"Laboratory of Antimicrobial Drug Discovery, School of Optometry and Vision Sciences, College of Biomedical and Life Sciences, Cardiff University, Cardiff CF24 4HQ, UK"},{"name":"Academic Ophthalmology, Mental Health and Clinical Neurosciences, School of Medicine, University of Nottingham, Nottingham NG7 2RD, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4683-6917","authenticated-orcid":false,"given":"Harminder S.","family":"Dua","sequence":"additional","affiliation":[{"name":"Academic Ophthalmology, Mental Health and Clinical Neurosciences, School of Medicine, University of Nottingham, Nottingham NG7 2RD, UK"},{"name":"Department of Ophthalmology, Queen\u2019s Medical Centre, Nottingham NG7 2UH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham R.","family":"Wallace","sequence":"additional","affiliation":[{"name":"Academic Unit of Ophthalmology, Department of Inflammation and Ageing, School of Infection, Inflammation and Immunology, College of Medicine and Health, University of Birmingham, Birmingham B15 2TT, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose R.","family":"Hombrebueno","sequence":"additional","affiliation":[{"name":"Academic Unit of Ophthalmology, Department of Inflammation and Ageing, School of Infection, Inflammation and Immunology, College of Medicine and Health, University of Birmingham, Birmingham B15 2TT, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4627-3496","authenticated-orcid":false,"given":"Saaeha","family":"Rauz","sequence":"additional","affiliation":[{"name":"Academic Unit of Ophthalmology, Department of Inflammation and Ageing, School of Infection, Inflammation and Immunology, College of Medicine and Health, University of Birmingham, Birmingham B15 2TT, UK"},{"name":"Birmingham and Midland Eye Centre, Sandwell and West Birmingham NHS Trust, Birmingham B18 71H, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1081-1141","authenticated-orcid":false,"given":"Darren S. J.","family":"Ting","sequence":"additional","affiliation":[{"name":"Academic Unit of Ophthalmology, Department of Inflammation and Ageing, School of Infection, Inflammation and Immunology, College of Medicine and Health, University of Birmingham, Birmingham B15 2TT, UK"},{"name":"Singapore Eye Research Institute, Singapore National Eye Centre, Singapore 169856, Singapore"},{"name":"Ophthalmology and Visual Sciences Academic Clinical Program (EYE-ACP), Duke-NUS Medical School, Singapore 169857, Singapore"},{"name":"Birmingham and Midland Eye Centre, Sandwell and West Birmingham NHS Trust, Birmingham B18 71H, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"100947","DOI":"10.1016\/j.lanmic.2024.07.010","article-title":"Antimicrobial resistance: A concise update","volume":"6","author":"Ho","year":"2025","journal-title":"Lancet Microbe"},{"key":"ref_2","unstructured":"O\u2019Neill, J. (2016). Tackling Drug-Resistant Infections Globally: Final Report and Recommendations, Wellcome Trust."},{"key":"ref_3","unstructured":"(2024). GBD 2021 Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance 1990\u20132021: A systematic analysis with forecasts to 2050. Lancet, 404, 1199\u20131226."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Shi, Z., Zhang, J., Tian, L., Xin, L., Liang, C., Ren, X., and Li, M. (2023). A Comprehensive Overview of the Antibiotics Approved in the Last Two Decades: Retrospects and Prospects. Molecules, 28, Correction in Molecules 2025, 30, 209.","DOI":"10.3390\/molecules30020209"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.mib.2019.10.008","article-title":"Antibiotics: Past, present and future","volume":"51","author":"Hutchings","year":"2019","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/s41579-023-00852-y","article-title":"Staphylococcus aureus host interactions and adaptation","volume":"21","author":"Howden","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"O\u2019Callaghan, R.J. (2018). The Pathogenesis of Staphylococcus aureus Eye Infections. Pathogens, 7.","DOI":"10.3390\/pathogens7010009"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jtos.2025.12.003","article-title":"Global burden, risk factors, causative organisms and antibiotic susceptibility patterns in bacterial keratitis","volume":"39","author":"Singh","year":"2026","journal-title":"Ocul. Surf."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Ting, D.S.J., Deshmukh, R., Ting, D.S.W., and Ang, M. (2023). Big data in corneal diseases and cataract: Current applications and future directions. Front. Big Data, 6.","DOI":"10.3389\/fdata.2023.1017420"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/s41579-024-01054-w","article-title":"ESKAPE pathogens: Antimicrobial resistance, epidemiology, clinical impact and therapeutics","volume":"22","author":"Miller","year":"2024","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2147\/IDR.S437920","article-title":"Antimicrobial Resistance Patterns of Staphylococcus Aureus Isolated at a General Hospital in Vietnam Between 2014 and 2021","volume":"17","author":"An","year":"2024","journal-title":"Infect. Drug Resist."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.tim.2017.05.011","article-title":"Transfer of Antibiotic Resistance in Staphylococcus aureus","volume":"25","author":"Haaber","year":"2017","journal-title":"Trends Microbiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e00181-19","DOI":"10.1128\/CMR.00181-19","article-title":"Antimicrobial Resistance in ESKAPE Pathogens","volume":"33","author":"Forde","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1001\/jamaophthalmol.2020.0155","article-title":"Trends in Antibiotic Resistance Among Ocular Microorganisms in the United States from 2009 to 2018","volume":"138","author":"Asbell","year":"2020","journal-title":"JAMA Ophthalmol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Vestergaard, M., Frees, D., and Ingmer, H. (2019). Antibiotic Resistance and the MRSA Problem. Microbiol. Spectr., 7.","DOI":"10.1128\/microbiolspec.GPP3-0057-2018"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jtos.2021.08.007","article-title":"The epidemiology of infectious keratitis","volume":"28","author":"Stapleton","year":"2023","journal-title":"Ocul. Surf."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/ICO.0b013e318156caf2","article-title":"Risk factors and causative organisms in microbial keratitis","volume":"27","author":"Green","year":"2008","journal-title":"Cornea"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Hsiao, C.-H., Kang, E.Y.-C., Yeh, L.-K., Ma, D.H.K., Chen, H.-C., Hung, K.-H., and Huang, Y.-C. (2022). Staphylococcus aureus Keratitis in Taiwan: Genotyping, Antibiotic Susceptibility, and Clinical Features. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231911703"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jtos.2025.06.008","article-title":"Moxifloxacin-resistant and moxifloxacin-susceptible Staphylococcus aureus Keratitis: Outcomes from a 10-year retrospective study","volume":"38","author":"Diacou","year":"2025","journal-title":"Ocul. Surf."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/ceo.14377","article-title":"Antimicrobial resistance in ocular infection: A review","volume":"52","author":"Kandel","year":"2024","journal-title":"Clin. Exp. Ophthalmol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1097\/ICL.0000000000000517","article-title":"Polymicrobial Keratitis with Cryptococcus curvatus, Candida parapsilosis, and Stenotrophomonas maltophilia After Penetrating Keratoplasty: A Rare Case Report with Literature Review","volume":"45","author":"Ting","year":"2019","journal-title":"Eye Contact Lens"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s00417-020-04681-0","article-title":"Microbial keratitis in Sydney, Australia: Risk factors, patient outcomes, and seasonal variation","volume":"258","author":"Khoo","year":"2020","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1016\/j.ophtha.2012.06.030","article-title":"Infectious keratitis progressing to endophthalmitis: A 15-year study of microbiology, associated factors, and clinical outcomes","volume":"119","author":"Henry","year":"2012","journal-title":"Ophthalmology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1038\/s41433-020-01333-9","article-title":"Calculating the economic burden of presumed microbial keratitis admissions at a tertiary referral centre in the UK","volume":"35","author":"Moussa","year":"2021","journal-title":"Eye"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/s41573-019-0058-8","article-title":"Antimicrobial host defence peptides: Functions and clinical potential","volume":"19","author":"Mookherjee","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Ting, D.S.J., Mohammed, I., Lakshminarayanan, R., Beuerman, R.W., and Dua, H.S. (2022). Host Defense Peptides at the Ocular Surface: Roles in Health and Major Diseases, and Therapeutic Potentials. Front. Med., 9.","DOI":"10.3389\/fmed.2022.835843"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41579-025-01200-y","article-title":"Antimicrobial peptides: Structure, functions and translational applications","volume":"23","author":"Souza","year":"2025","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/s41579-021-00585-w","article-title":"Antibiofilm activity of host defence peptides: Complexity provides opportunities","volume":"19","author":"Hancock","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"18304","DOI":"10.1038\/s41598-021-97821-3","article-title":"Hybrid derivative of cathelicidin and human beta defensin-2 against Gram-positive bacteria: A novel approach for the treatment of bacterial keratitis","volume":"11","author":"Ting","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Ting, D.S.J., Li, J., Verma, C.S., Goh, E.T.L., Nubile, M., Mastropasqua, L., Said, D.G., Beuerman, R.W., Lakshminarayanan, R., and Mohammed, I. (2021). Evaluation of Host Defense Peptide (CaD23)-Antibiotic Interaction and Mechanism of Action: Insights From Experimental and Molecular Dynamics Simulations Studies. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.731499"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Ting, D.S.J., Beuerman, R.W., Dua, H.S., Lakshminarayanan, R., and Mohammed, I. (2020). Strategies in Translating the Therapeutic Potentials of Host Defense Peptides. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.00983"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"4365","DOI":"10.1038\/s41598-022-08247-4","article-title":"A novel hybrid peptide composed of LfcinB6 and KR-12-a4 with enhanced antimicrobial, anti-inflammatory and anti-biofilm activities","volume":"12","author":"Ajish","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Taheri-Araghi, S. (2024). Synergistic action of antimicrobial peptides and antibiotics: Current understanding and future directions. Front. Microbiol., 15.","DOI":"10.3389\/fmicb.2024.1390765"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Kampshoff, F., Willcox, M.D.P., and Dutta, D. (2019). A Pilot Study of the Synergy between Two Antimicrobial Peptides and Two Common Antibiotics. Antibiotics, 8.","DOI":"10.3390\/antibiotics8020060"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.bbamem.2017.01.037","article-title":"LL-37-derived membrane-active FK-13 analogs possessing cell selectivity, anti-biofilm activity and synergy with chloramphenicol and anti-inflammatory activity","volume":"1859","author":"Rajasekaran","year":"2017","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1128\/AAC.05637-11","article-title":"Decoding the Functional Roles of Cationic Side Chains of the Major Antimicrobial Region of Human Cathelicidin LL-37","volume":"56","author":"Wang","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"a027029","DOI":"10.1101\/cshperspect.a027029","article-title":"Aminoglycosides: An Overview","volume":"6","author":"Krause","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1751-7915.2008.00063.x","article-title":"Mechanism of action of and resistance to quinolones","volume":"2","author":"Madurga","year":"2009","journal-title":"Microb. Biotechnol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"8007","DOI":"10.1007\/s00253-022-12272-8","article-title":"Cephalosporins as key lead generation beta-lactam antibiotics","volume":"106","author":"Lin","year":"2022","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e0154722","DOI":"10.1128\/aem.01547-22","article-title":"Molecular Mechanism of Chloramphenicol and Thiamphenicol Resistance Mediated by a Novel Oxidase, CmO, in Sphingomonadaceae","volume":"89","author":"Ma","year":"2023","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"a025262","DOI":"10.1101\/cshperspect.a025262","article-title":"Fosfomycin: Mechanism and Resistance","volume":"7","author":"Silver","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/pro.3819","article-title":"Molecular mechanisms of vancomycin resistance","volume":"29","author":"Stogios","year":"2020","journal-title":"Protein Sci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.1038\/s41467-019-12364-6","article-title":"Integrated evolutionary analysis reveals antimicrobial peptides with limited resistance","volume":"10","author":"Spohn","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1007\/s00417-023-06003-6","article-title":"Practice patterns in the management of bacterial keratitis: A five-continent survey","volume":"261","author":"Wespiser","year":"2023","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Ting, D.S.J., Cairns, J., Gopal, B.P., Ho, C.S., Krstic, L., Elsahn, A., Lister, M., Said, D.G., and Dua, H.S. (2021). Risk Factors, Clinical Outcomes, and Prognostic Factors of Bacterial Keratitis: The Nottingham Infectious Keratitis Study. Front. Med., 8.","DOI":"10.3389\/fmed.2021.715118"},{"key":"ref_46","unstructured":"(2026, April 01). How Safe Is This Drug?. Available online: https:\/\/toxedfoundation.org\/how-safe-is-this-drug\/."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1038\/s41598-019-40216-2","article-title":"Proteolytic Degradation of reduced Human Beta Defensin 1 generates a Novel Antibiotic Octapeptide","volume":"9","author":"Wendler","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_48","unstructured":"(2026, April 01). WHO List of Medically Important Antimicrobials. Available online: https:\/\/cdn.who.int\/media\/docs\/default-source\/gcp\/who-mia-list-2024-lv.pdf."},{"key":"ref_49","first-page":"Cd015350","article-title":"Topical antibiotics for treating bacterial keratitis: A network meta-analysis","volume":"7","author":"Song","year":"2025","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_50","unstructured":"Clinical and Laboratory Standards Institute (2024). CLSI M07\u2014Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, Clinical and Laboratory Standards Institute."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"145923","DOI":"10.1016\/j.cej.2023.145923","article-title":"Enhancing the stability of antimicrobial peptides: From design strategies to applications","volume":"475","author":"Xu","year":"2023","journal-title":"Chem. Eng. J."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg301","article-title":"Synergy, antagonism, and what the chequerboard puts between them","volume":"52","author":"Odds","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s44259-025-00142-y","article-title":"Biosynthetic \u03b5-poly-L-lysine for the treatment of extensively- and pan-drug-resistant Pseudomonas aeruginosa","volume":"3","author":"Ting","year":"2025","journal-title":"npj Antimicrob. Resist."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/12\/5573\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T04:17:07Z","timestamp":1782533827000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/12\/5573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,20]]},"references-count":53,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["ijms27125573"],"URL":"https:\/\/doi.org\/10.3390\/ijms27125573","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,20]]}}}